These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8938272)

  • 1. The next wave of recombinant and synthetic anticancer vaccines.
    Irvine KR; Restifo NP
    Semin Cancer Biol; 1995 Dec; 6(6):337-47. PubMed ID: 8938272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines in the treatment of cancer.
    Baltz JK
    Am J Health Syst Pharm; 1995 Nov; 52(22):2574-85; quiz 2594-5. PubMed ID: 8590245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.
    Chamberlain RS; Carroll MW; Bronte V; Hwu P; Warren S; Yang JC; Nishimura M; Moss B; Rosenberg SA; Restifo NP
    Cancer Res; 1996 Jun; 56(12):2832-6. PubMed ID: 8665522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition of tumor antigens suitable for vaccine construction.
    Lewis JJ; Houghton AN
    Semin Cancer Biol; 1995 Dec; 6(6):321-7. PubMed ID: 8938270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and clinical studies of recombinant poxvirus vaccines for carcinoma therapy.
    Arlen PM; Gulley JL; Madan RA; Hodge JW; Schlom J
    Crit Rev Immunol; 2007; 27(5):451-62. PubMed ID: 18197807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine.
    Graham RA; Burchell JM; Taylor-Papadimitriou J
    Cancer Immunol Immunother; 1996 Feb; 42(2):71-80. PubMed ID: 8620523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development.
    Charles LG; Xie YC; Restifo NP; Roessler B; Sanda MG
    World J Urol; 2000 Apr; 18(2):136-42. PubMed ID: 10854149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diversity of T-cell co-stimulation in the induction of antitumor immunity.
    Schlom J; Hodge JW
    Immunol Rev; 1999 Aug; 170():73-84. PubMed ID: 10566143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity.
    Speiser DE; Romero P
    Semin Immunol; 2010 Jun; 22(3):144-54. PubMed ID: 20413326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines.
    Pardoll DM
    Immunol Today; 1993 Jun; 14(6):310-6. PubMed ID: 8397772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel recombinant alphaviral and adenoviral vectors for cancer immunotherapy.
    Osada T; Morse MA; Hobeika A; Lyerly HK
    Semin Oncol; 2012 Jun; 39(3):305-10. PubMed ID: 22595053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered tumor vaccines.
    Pardoll DM
    Ann N Y Acad Sci; 1993 Aug; 690():301-10. PubMed ID: 7690216
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer vaccines get a shot in the arm.
    Cohen J
    Science; 1993 Nov; 262(5135):841-3. PubMed ID: 8235605
    [No Abstract]   [Full Text] [Related]  

  • 14. Epitope selection and development of peptide based vaccines to treat cancer.
    Celis E; Sette A; Grey HM
    Semin Cancer Biol; 1995 Dec; 6(6):329-36. PubMed ID: 8938271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
    Rao JB; Chamberlain RS; Bronte V; Carroll MW; Irvine KR; Moss B; Rosenberg SA; Restifo NP
    J Immunol; 1996 May; 156(9):3357-65. PubMed ID: 8617961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer vaccines: scientific bases and clinical developments].
    Bellet D
    Bull Cancer; 1995 Nov; 82(11):899-909. PubMed ID: 8535016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-idiotypic monoclonal antibody cancer vaccines.
    Chapman PB
    Semin Cancer Biol; 1995 Dec; 6(6):367-74. PubMed ID: 8938275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRICOM vector based cancer vaccines.
    Garnett CT; Greiner JW; Tsang KY; Kudo-Saito C; Grosenbach DW; Chakraborty M; Gulley JL; Arlen PM; Schlom J; Hodge JW
    Curr Pharm Des; 2006; 12(3):351-61. PubMed ID: 16454749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector-based delivery of tumor-associated antigens and T-cell co-stimulatory molecules in the induction of immune responses and anti-tumor immunity.
    Hodge JW; Grosenbach DW; Schlom J
    Cancer Detect Prev; 2002; 26(4):275-91. PubMed ID: 12430632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for enhancing the immunogenicity of tumors.
    Pardoll DM
    Curr Opin Immunol; 1993 Oct; 5(5):719-25. PubMed ID: 7694593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.